Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Marais

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Metformin: a diabetes drug for cancer, or a cancer drug for diabetics?Matthew Martin, Richard Marais
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Is BRAF the Achilles' Heel of thyroid cancer?Antonio Chiloeches, Richard Marais
The FEBS Journal|July 13, 2005
Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft für Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in BrusselsNicolas Dumaz, Richard Marais
Cancer Cell|October 19, 2004
Guilty as charged: B-RAF is a human oncogeneMathew J Garnett, Richard Marais
Cancer Discovery|May 10, 2013
Deja Vu: EGF receptors drive resistance to BRAF inhibitorsMaria Romina Girotti, Richard Marais
Nature|October 5, 2017
Cancer: Tumours addicted to drugs are vulnerableRebecca J Lee, Richard Marais
Nature|May 22, 2009
Cancer: Melanoma troops massedPaul H Huang, Richard Marais
Cancer Discovery|February 10, 2012
New insight puts CRAF in sight as a therapeutic targetAna Paula Rebocho, Richard Marais
Molecular and Cellular Biology|June 22, 2002
14-3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelityYvonne Light, Hugh Paterson, Richard Marais
Molecular and Cellular Biology|May 9, 2002
Cyclic AMP blocks cell growth through Raf-1-dependent and Raf-1-independent mechanismsNicolas Dumaz, Yvonne Light, Richard Marais
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Metformin: a diabetes drug for cancer, or a cancer drug for diabetics?Matthew Martin, Richard Marais
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Is BRAF the Achilles' Heel of thyroid cancer?Antonio Chiloeches, Richard Marais
The FEBS Journal|July 13, 2005
Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft für Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in BrusselsNicolas Dumaz, Richard Marais
Cancer Cell|October 19, 2004
Guilty as charged: B-RAF is a human oncogeneMathew J Garnett, Richard Marais
Cancer Discovery|May 10, 2013
Deja Vu: EGF receptors drive resistance to BRAF inhibitorsMaria Romina Girotti, Richard Marais
Nature|October 5, 2017
Cancer: Tumours addicted to drugs are vulnerableRebecca J Lee, Richard Marais
Nature|May 22, 2009
Cancer: Melanoma troops massedPaul H Huang, Richard Marais
Cancer Discovery|February 10, 2012
New insight puts CRAF in sight as a therapeutic targetAna Paula Rebocho, Richard Marais
Molecular and Cellular Biology|June 22, 2002
14-3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelityYvonne Light, Hugh Paterson, Richard Marais
Molecular and Cellular Biology|May 9, 2002
Cyclic AMP blocks cell growth through Raf-1-dependent and Raf-1-independent mechanismsNicolas Dumaz, Yvonne Light, Richard Marais
Pageof 19